U.S., April 18 -- ClinicalTrials.gov registry received information related to the study (NCT07537426) titled 'The Efficacy of Intradermal Acupuncture for Ocular Surface Diseases After Intractable Faci... Read More
U.S., April 18 -- ClinicalTrials.gov registry received information related to the study (NCT07537205) titled 'The Effects of a Nurse-led TGA-based Pre-rehabilitation Planning on Perioperative Outcomes... Read More
U.S., April 18 -- ClinicalTrials.gov registry received information related to the study (NCT07535567) titled 'Postoperative Radiotherapy With Nimotuzumab ± Benmelstobart in Intermediate-Risk Head... Read More
U.S., April 18 -- ClinicalTrials.gov registry received information related to the study (NCT07536256) titled 'Community Connections Through Native Hawaiian Cultural Values to Strengthen Youth Resilien... Read More
U.S., April 18 -- ClinicalTrials.gov registry received information related to the study (NCT07535840) titled 'A Clinical Trial of Firsekibart, Tislelizumab, and Lenvatinib in Patients With Unresectabl... Read More
U.S., April 18 -- ClinicalTrials.gov registry received information related to the study (NCT07536191) titled 'GALLVIA Trial: EUS-Guided vs Transpapillary Gallbladder Drainage for Acute Calculous Chole... Read More
Singapore, April 18 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combi... Read More
Singapore, April 18 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the p... Read More
Singapore, April 18 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-98650... Read More
Singapore, April 18 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemother... Read More